No significant benefit seen for two doses when the age range was broadened to children younger than 9 years
FRIDAY, Oct. 17, 2025 (HealthDay News) — Receiving two doses of inactivated influenza vaccine (IIV) in the first year of influenza vaccination is associated with improved protection for children younger than 3 years versus one dose, according to a study published online Oct. 3 in JAMA Network Open.
Jessie J. Goldsmith, from University of Melbourne in Australia, and colleagues conducted a systematic literature review to estimate the increase in protection associated with the second dose of influenza vaccine for influenza vaccine-naive children younger than 9 years.
Based on 51 studies (415,050 participants), the researchers found that the pooled absolute increase in vaccine effectiveness of a second inactivated influenza vaccine dose in the first year of vaccination was 15 percentage points (pp) for those younger than 9 years (95 percent confidence interval [CI], −2.8 pp to 33 pp) and 28 pp (95 percent CI, 4.7 pp to 51 pp) for children younger than 3 years. It was not possible to assess the incremental benefit associated with a second dose of live attenuated influenza vaccine.
“Our findings suggest the second dose of inactivated influenza vaccine confers additional protection for influenza vaccine-naive children <3 years but that the benefit attenuates with age,” the authors write.
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders
Dose-Dependent Link Seen for Clomiphene Citrate, Adverse Perinatal Outcomes
Effect of Preparation Techniques Before Embryo Transfer Appears to Be Limited
Dietary Nitrate From Beetroot Juice Promising for Pregnant Women With CKD